Abstract
Benzene is an established leukemogen increasingly linked to cardiovascular injury, but whether low-level exposure depletes the circulating progenitor cells that maintain vascular repair is unknown. We studied 202 workers from 12 benzene-related enterprises in Ningbo, China (May–October 2022), quantifying six urinary benzene, toluene, and xylene metabolites and enumerating CD31+ cells, CD34+ cells, and CD34+CD31+CD45+ circulating progenitor cells (CPCs) by ISHAGE-consistent flow cytometry. Two hypotheses were prespecified with Holm–Bonferroni control: urinary trans,trans-muconic acid (tt-MA) would be inversely associated with CD34+ cells and CPCs. Per doubling of tt-MA, CD34+ cells were 11.8% lower (95% CI: −21.7 to −0.6; q = 0.045) and CPCs were 5.1% lower (−9.3 to −0.8; q = 0.045) after covariate adjustment. The tt-MA–CD34+ association persisted among never-smokers (−14.0%; 95% CI: −26.0 to −0.2), deficits were concentrated in the highest tt-MA quartile (CD34+: −45.6%; P-trend = 0.042), and no toluene- or xylene-derived metabolite was associated with any outcome. Low-level benzene exposure is associated with benzene-specific depletion of circulating vascular-repair progenitor cells, a candidate early mechanism of cardiovascular injury that warrants longitudinal evaluation.